Want to see NGEN full AI Analyst Report?
NervGen Pharma (NGEN) Ownership - Who Owns NervGen Pharma?
NervGen Pharma (NGEN) Ownership Overview
- 15.64% Insiders
- 0.06% Mutual Funds
- 0.15% Other Institutional Investors
- 0.06% ETFs
- 84.09% Public Companies and Individual Investors
The ownership structure of NervGen Pharma (NGEN) stock is a mix of institutional, retail, and individual investors. Approximately 0.27% of the company’s stock is owned by Institutional Investors, 15.64% is owned by Insiders, and 84.09% is owned by Public Companies and Individual Investors.
The ownership structure of NervGen Pharma (NGEN) stock is a mix of institutional, retail, and individual investors. Approximately 0.27% of the company’s stock is owned by Institutional Investors, 15.64% is owned by Insiders, and 84.09% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Jun 03, 2026 | Adam Rogers | $2,000,000 | |
| Jun 01, 2026 | John Ruffolo | $18,268 | |
| May 04, 2026 | Harold Punnett | $15,912 | |
| Apr 08, 2026 | Krista Mckerracher | $63,064 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2026 | Woodline Partners Lp | $516,030 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Adam Rogers | 14,751,027 | Insider | 13.71% | 20,208,907 |
| Harold Punnett | 1,196,960 | Insider | 1.11% | 1,639,835 |
| Brian E Bayley | 615,000 | Insider | 0.57% | 842,550 |
| Michael Rockefeller | 250,500 | Institution | 0.23% | 343,185 |
| Randall Kaye | 168,974 | Insider | 0.16% | 231,494 |
| John Ruffolo | 79,198 | Insider | 0.07% | 108,501 |
| Fidelity Concord Street Trust | 67,449 | Institution | 0.06% | 92,405 |
| State Street | 61,607 | Institution | 0.06% | 84,402 |
| Krista Mckerracher | 17,627 | Insider | 0.02% | 24,149 |
| Ishares | 8,257 | Institution | <0.01% | 11,312 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Fidelity Concord Street Trust | 67,449 | Institution | 0.06% | 92,405 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| State Street, GWX ETF | 61,607 | Institution | 0.06% | 88,714 |
| iShares, IBRN ETF | 8,257 | Institution | <0.01% | 11,890 |
FAQ
Who Owns NervGen Pharma (NGEN)?
According to the latest TipRanks data, approximately 0.27% of the company's stock is held by institutional investors, 15.64% is held by insiders, and 84.09% is held by public companies and individual investors.
What percentage of NervGen Pharma (NGEN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.27% of NervGen Pharma (NGEN) stock is held by institutional investors: 0.06% by mutual funds, 0.06% by ETFs and 0.15% by other institutional investors.
What percentage of NervGen Pharma (NGEN) stock is held by retail investors?
According to the latest TipRanks data, approximately 84.09% of NervGen Pharma (NGEN) stock is held by public companies and individual investors.
Who owns the most shares of NervGen Pharma (NGEN)?
Adam Rogers owns the most shares of NervGen Pharma (NGEN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.